Before I came to Xconomy, I didn’t know much about the Kansas City-based Kauffman Foundation beyond what I heard on the radio. If you’re an NPR listener like me, you’ve probably heard their underwriting plug that says it’s the “Foundation of Entrepreneurship.” But then I started covering stories like the foundation’s annual New Economy Index, … Continue reading “The Kauffman Foundation: Bringing Entrepreneurship Up to Date in Kansas City”
Top 10 Highlights from FiReGlobal: Michael Dell, Lee Hartwell, Irwin Jacobs, and More
I can’t do justice to a comprehensive review of yesterday’s FiReGlobal (West Coast) conference at the Four Seasons Hotel in Seattle. Instead, I’ll just give a few of my key takeaways. The all-day event, organized by Strategic News Service, focused on how to solve some of the most pressing problems in technology, business, and society—in … Continue reading “Top 10 Highlights from FiReGlobal: Michael Dell, Lee Hartwell, Irwin Jacobs, and More”
Cisco Snags Starent for $2.9B, Rocket Software Raises $91.9M, & More Boston-Area Deals News
Not much deals news to round up this week, thanks to the Monday holiday and the fact that last week’s roundup slipped to this week. But just in case you missed it… —Tewksbury, MA-based Starent Networks (NASDAQ:[[ticker:STAR]]) agreed to be acquired by technology giant Cisco (NASDAQ:[[ticker:CSCO]]) for a healthy $2.9 billion. Starent, which went public … Continue reading “Cisco Snags Starent for $2.9B, Rocket Software Raises $91.9M, & More Boston-Area Deals News”
Flexion Therapeutics Secures $33,000,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=261bcfe5-9389-49a5-ac75-0a2f8c696d10&Preview=1 Date 10/16/2009 Company Name Flexion Therapeutics Mailing Address 300 TradeCenter Woburn, MA 01801 Company Description Flexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners. Website http://www.flexiontherapeutics.com Transaction … Continue reading “Flexion Therapeutics Secures $33,000,000 Series A Funding”
Augmenix Obtains $6,100,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0db3f518-5f0f-4084-8b6f-4ce027f9f671&Preview=1 Date 10/16/2009 Company Name Augmenix Mailing Address 204 2nd Avenue Waltham, MA 02451 Company Description Augmenix™, Inc. is a privately held medical device company developing in-situ formed, space-filling hydrogels specifically for radiation oncology and cancer surgery indications. Augmenix, Inc.’s initial product will be the first synthetic tissue spacer designed and indicated … Continue reading “Augmenix Obtains $6,100,000 Series B Round”
Jackpot Rewards Receives $12,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=43025522-b19f-47ad-a341-43a6d9b1d4fa&Preview=1 Date 10/16/2009 Company Name Jackpot Rewards Mailing Address 275 Grove Street Newton, MA 02466 Company Description The company operates on online lottery website. Website http://www.jackpotrewards.com Transaction Type Debt Transaction Amount $12,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor Undisclosed
Overtone Receives $2,500,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=025b6e54-d33e-4f81-b4f3-c29c22e79537&Preview=1 Date 10/16/2009 Company Name Overtone Mailing Address 44 Montgomery St. San Francisco, CA 94104 Company Description Island Data Corporation delivers real-time customer intelligence to many of the world’s most innovative global enterprises. Going beyond conventional market research tools, Island Data’s software-as-a-service, Insight RT™, gleans actionable intelligence from uniquely valuable unstructured customer … Continue reading “Overtone Receives $2,500,000 Series A Funding Round”
Syneron Acquires Primaeva Medical for $7,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=75137d34-bffb-4b02-b07c-535a7e5e31fa&Preview=1 Date 10/16/2009 Company Name Primaeva Medical Mailing Address 4160 Hacienda Drive Pleasanton, CA 94588 Company Description Primaeva Medical is dedicated to providing the aesthetic physician superior new tools for Restoring Youth for their patients who want to reverse the signs of aging. Website http://www.primaevamedical.com Transaction Type M&A Transaction Amount $7,000,000 Transaction … Continue reading “Syneron Acquires Primaeva Medical for $7,000,000”
San Diego-based SmartDrive Systems Raises $12M in Venture Funding
SmartDrive Systems, a San Diego company that uses video recording technology and web-based services to reduce the costs of operating motor vehicle fleets, has raised $12 million in venture capital in a deal that could be worth as much as $25 million, according to a regulatory filing. The company was founded in 2004 by James … Continue reading “San Diego-based SmartDrive Systems Raises $12M in Venture Funding”
Bellevue-based AudienceScience Gets $15M Financing Deal For Targeted Digital Advertising
AudienceScience, the Bellevue, WA-based company that helps advertisers connect with targeted audiences online, has pulled in about $4 million in new equity financing as part of a total deal worth $15.1 million, according to a regulatory filing. The new cash infusion is actually only one component of the transaction, which includes $10.8 million worth of … Continue reading “Bellevue-based AudienceScience Gets $15M Financing Deal For Targeted Digital Advertising”
Future Forward 2009
This year’s installment of the Future Forward Retreat hits on New Marketing, New Rules of Angel Investing, Visualizing Information in New Ways, and the catchy “Long Road to Global Domination.” As a bonus, participants will be able to suggest their own topics for lunchtime roundtable discussions. The afternoon program includes demo sessions from promising New … Continue reading “Future Forward 2009”
Cheezburger Network’s Ben Huh on Startup Strategy, Expansion, and Making It Big
It took about a year and a half before I could even begin to understand the I Can Has Cheezburger (or “LOLcats”) phenomenon online. The mundane yet bizarre cat pictures. The misspelled captions. The curious Internet-slang grammar. They were kind of funny, but mostly they were weird—and, at times, even a little annoying. Yet millions … Continue reading “Cheezburger Network’s Ben Huh on Startup Strategy, Expansion, and Making It Big”
La Jolla Pharmaceutical Sets Vote to Shut Down
La Jolla Pharmaceutical (NASDAQ: [[ticker:LJPC]]) has scheduled a special shareholder meeting for Oct. 30 to vote on a plan of liquidation and dissolution. If approved, the biotech expects to satisfy remaining debts and distribute remaining cash to shareholders. With estimated cash of $4.4 million at the end of August, the company estimates the distribution to … Continue reading “La Jolla Pharmaceutical Sets Vote to Shut Down”
Plan to Provide Federal Funding for Early-Stage Investments Perfect for San Diego’s Innovation Economy, Says Connect’s Roth
Back in August, Connect CEO Duane Roth outlined an initiative to address a dearth of venture capital investment by seeking to develop alternative funding sources for San Diego’s early-stage technology companies. A key part of the non-profit group’s initiative is to pursue additional federal support—and now that effort is facing its first major test as … Continue reading “Plan to Provide Federal Funding for Early-Stage Investments Perfect for San Diego’s Innovation Economy, Says Connect’s Roth”
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News
The news has been breaking fast and furious here at Xconomy, just as we are putting the finishing touches on a terrific event on Monday that will explore the 20-year outlook for the Seattle region as a life sciences hub. —Xconomy dug up an exclusive late Friday afternoon from a couple SEC filings that showed … Continue reading “Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News”
Eastbourne Dumps Amylin Shares, Illumina Inks Licensing Deal, Avanir Releases Pseudobulbar Affect Data, & More San Diego Life Sciences News
A quiet epilogue to last spring’s heated Amylin proxy battle was the lead story in an otherwise slow week for San Diego life sciences news. —Eastbourne Capital, which won a partial victory in a proxy fight against Amylin Pharmaceuticals earlier this year, sold its entire stake in the San Diego diabetes company. The San Rafael, … Continue reading “Eastbourne Dumps Amylin Shares, Illumina Inks Licensing Deal, Avanir Releases Pseudobulbar Affect Data, & More San Diego Life Sciences News”
Deep Dive Into MA Deals Data for Q3—With Lots of Pictures
Just about everyone loves a good pie…chart, that is. If you’re one of those, read on. On Tuesday, we ran a story here in Boston about all the September venture deals in Massachusetts—and then my colleague Bruce followed that up a bit later that same day with a national roundup of third-quarter venture figures. Both … Continue reading “Deep Dive Into MA Deals Data for Q3—With Lots of Pictures”
Six Red Flags to Watch Out For in a Biotech, From Dendreon Co-Founder Chris Henney
Yesterday, we provided a rundown of the six hallmarks of a successful biotech company, according to Christopher Henney, the biotech pioneer who co-founded three of Seattle’s top biotechs—Immunex, Icos, and Dendreon. He made his remarks to an audience of about 100 investing professionals at the CFA Society meeting on Oct. 8 in Seattle. Today, we … Continue reading “Six Red Flags to Watch Out For in a Biotech, From Dendreon Co-Founder Chris Henney”
The 20-Year Future for Seattle Biotech, As Told By Industry Visionaries, Coming Monday
What is the single best thing that has happened in Seattle life sciences in the past five years? How might that make a difference over the next two decades as this region strives to become a more vibrant cluster for life sciences innovation? These are the kinds of questions you don’t see explored much in … Continue reading “The 20-Year Future for Seattle Biotech, As Told By Industry Visionaries, Coming Monday”
How to Tap Russia for Biomedical Breakthroughs: Lessons from Boston BioCom
Boston is an international hotbed of biotech research. So why would a company called Boston BioCom specialize, as it does, in bringing biomedical discoveries to the Hub from Russia? To hear the folks at Boston BioCom tell it, Russia has some biotech brawn of its own. New York-based drug giant Pfizer (NYSE:[[ticker:PFE]]) invested $10 million … Continue reading “How to Tap Russia for Biomedical Breakthroughs: Lessons from Boston BioCom”
What Boston’s Life Sciences Community is Taking for Granted
I spent an enlightening week in Tokyo earlier this month participating in the Kauffman Fellows Japan Summit. This summit was the brainchild of three visionary Kauffman Fellows who are on a mission to instill entrepreneurship into the Japanese culture. During the three days we heard about the current (dismal) status of venture capital and entrepreneurial … Continue reading “What Boston’s Life Sciences Community is Taking for Granted”
Good Data Secures $2,500,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1412fa5d-5b29-4fb7-a4b3-12a024498a48&Preview=1 Date 10/15/2009 Company Name Good Data Mailing Address 989 Market Street San Francisco, CA 94103 Company Description Good Data Corporation was founded with the mission to provide a platform for collaborative analytics. We believe that sharing and teamwork allows our users to move past isolated reports and arrive at the true … Continue reading “Good Data Secures $2,500,000 New Round”
Spigit Garners $10,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=45651b7f-9497-4461-bd7a-9d70ab79737d&Preview=1 Date 10/15/2009 Company Name Spigit Mailing Address 311 Ray Street Pleasanton, CA 94566 Company Description Spigit is a purpose built social networking tool used by leading companies to connect their employees, customers and business partners for idea and innovation discovery. Using sophisticated analytics built on advanced mathematics, Spigit takes us beyond … Continue reading “Spigit Garners $10,000,000 New Round”
Box.net Obtains $2,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f54aa330-1d26-4234-94be-f1fab47c4184&Preview=1 Date 10/15/2009 Company Name Box.net Mailing Address 409 Sherman Ave. Palo Alto, CA 94306 Company Description Launched officially in March of 2006, Box.net currently provides secure online file storage and sharing functionality to over 500,000 registered users, serving files to millions of people across the world. Box.net’s unique platform allows personal … Continue reading “Box.net Obtains $2,000,000 New Financing Round”
Illumina Countersues Life Technologies
San Diego-based Illumina (NASDAQ: [[ticker:ILMN]]) and its Solexa subsidiary are countersuing Carlbad, CA-based Life Technologies (NASDAQ: [[ticker:LIFE]]) and Applied Biosystems in a patent dispute over gene sequencing technologies. In a statement today, Illumina and Solexa denied allegations that Life and Applied Biosystems raise in their Sept. 21 lawsuit, assert that Applied Biosystems’ patents are invalid, … Continue reading “Illumina Countersues Life Technologies”
New Life Sciences Startup Shows UCSD Technology Can Boost Immune Response to Cancer in Mice
Research published today has revealed the existence of a new San Diego life sciences company that is working to commercialize anti-cancer technologies intended to boost the immune system to resist tumor growth. A paper in the journal PloS ONE shows that a gene for a specially engineered form of a protein called CD40 ligand (CD40L), … Continue reading “New Life Sciences Startup Shows UCSD Technology Can Boost Immune Response to Cancer in Mice”
Clean Edge, PayScale Survey Jobs in Cleantech
Portland, OR-based research and publishing firm Clean Edge released a report today on job trends in the cleantech and energy industry. The highlights include a survey of salaries across a range of cleantech positions worldwide, performed in partnership with Seattle-based PayScale, the salary comparison firm. For example, the survey tracked median salaries for solar energy … Continue reading “Clean Edge, PayScale Survey Jobs in Cleantech”
Amazon Invests in Engine Yard, PopCap Raises $22.5M, Omeros Goes Public, & More Seattle-Area Deals News
The deals rained down on the Northwest this past week. We saw some strong activity in biotech, gaming, and software. —Integrated Diagnostics, the new biotech company founded by Lee Hood, has secured $30 million in venture funding from Menlo Park, CA-based InterWest Partners, the U.K.-based Wellcome Trust, and Germany-based dievini Hopp Biotech holding, as Luke … Continue reading “Amazon Invests in Engine Yard, PopCap Raises $22.5M, Omeros Goes Public, & More Seattle-Area Deals News”
Semtek Raises $6.7M in Series B Round
San Diego’s Semtek Innovative Solutions has raised more than $6.7 million in a planned Series B round of $8 million, according to a recent regulatory filing. Semtek, which is commercializing technologies for preventing the theft of credit card data and identifying counterfeit credit cards, said earlier this month that VeriFone Holdings now owns a 19.9 … Continue reading “Semtek Raises $6.7M in Series B Round”
Skype Reported to be in Talks to Buy San Diego’s Gizmo5
When I wrote about MP3.com founder Michael Robertson in December, the San Diego serial entrepreneur had just launched Gizmo5, an updated version of his free VoIP (Voice Over Internet Protocol) software and peer-to-peer network for making Internet-based phone calls. In my headline, I asked, “Michael Robertson is Calling, But Will Anybody Answer?” Ten months later, … Continue reading “Skype Reported to be in Talks to Buy San Diego’s Gizmo5”
Appswell Tests the Crowdsourcing Model for iPhone Apps
Last time I checked, there were 85,000 iPhone applications in Apple’s iTunes App Store, a number that seems to grow by thousands every week. But most of those apps were dreamed up by developers, not by average users. Now there’s a way for anyone with a bright idea for an iPhone app to submit it—and, … Continue reading “Appswell Tests the Crowdsourcing Model for iPhone Apps”
Alkermes Anti-Addiction Drug Fares Well in Clinical Trials, Amgen Takes Aim at Drug-Development Success Rate, & More Boston-Area Life Sciences News
It’s been a short week and a long weekend since last I rounded up New England’s life sciences news, but there were still a few stories worth mentioning. —Luke took an in-depth look at giant Amgen’s (NASDAQ: [[ticker:AMGN]]) efforts to boost its rate of success in getting new drugs to market. Though Amgen is based … Continue reading “Alkermes Anti-Addiction Drug Fares Well in Clinical Trials, Amgen Takes Aim at Drug-Development Success Rate, & More Boston-Area Life Sciences News”
Lee Hood’s New Company Snags $30M to Spot Cancer and Alzheimer’s in Early Days
Lee Hood, the legendary researcher and entrepreneur who invented machines that made the Human Genome Project possible, has secured $30 million in venture capital for a startup that aims to detect cancer and neurodegenerative diseases like Alzheimer’s in their earliest and most treatable stages. The new company is called Integrated Diagnostics, or InDi for short … Continue reading “Lee Hood’s New Company Snags $30M to Spot Cancer and Alzheimer’s in Early Days”
Sirtris Advancing No. 1 Drug into Mid-Stage Clinical Trials for Type 2 Diabetes
Cambridge, MA, biotech standout Sirtris has been a quieter operation since it became a subsidiary of drug giant GlaxoSmithKline last summer. But the firm’s drugs, heralded for their potential anti-aging effects, appear to be advancing through the clinic without a hitch. Brian Gallagher, senior director of corporate development at Sirtris, disclosed during a recent meeting … Continue reading “Sirtris Advancing No. 1 Drug into Mid-Stage Clinical Trials for Type 2 Diabetes”
Algae Biofuels Skeptics Emphasize Need for Realistic Outlook and Business Discipline
When the organizers of the annual Algae Biomass Summit convene to begin planning for next year’s event, they might consider renaming it the Algae Biomass Smackdown. It might be more accurate, considering the air of skepticism that seemed to pervade some of the sessions I attended during the three-day conference that was held last week … Continue reading “Algae Biofuels Skeptics Emphasize Need for Realistic Outlook and Business Discipline”
Former Zango Execs Unveil BigDoor Media to Help Web Publishers Make More Money
It’s one of the great mysteries of the modern Internet. How can Web publishers make more money from their content? For everything from blogs and journalism to games and entertainment, publishers and software companies alike have been trying to solve this problem for many years. Now BigDoor Media, a six-person startup in Bellevue, WA, thinks … Continue reading “Former Zango Execs Unveil BigDoor Media to Help Web Publishers Make More Money”
Six Tips on How to Spot a Winning Biotech, From Dendreon Co-Founder Chris Henney
Investing in biotech can be scary. Only one out of 10 new drug candidates ever makes it through the gauntlet of clinical trials to become an FDA approved product, and it usually takes hundreds of millions of dollars and a decade or more of research to separate the winners from the losers. Investors usually can’t … Continue reading “Six Tips on How to Spot a Winning Biotech, From Dendreon Co-Founder Chris Henney”
Book of Odds Comes Out of Stealth to Make Intuitive Sense of Statistics—But Can It Sell Ads?
Despite the fact that “Google it” is now synonymous with “look it up,” Google itself isn’t a primary reference source. It merely aggregates facts and claims from everywhere else. If you wanted to create a genuinely new reference work on the scale of a dictionary or an encyclopedia—even if it lived online—you’d still have to … Continue reading “Book of Odds Comes Out of Stealth to Make Intuitive Sense of Statistics—But Can It Sell Ads?”
Integrated Diagnostics Receives $30,000,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d5674d5a-4a0b-4106-930c-217e3a0589c6&Preview=1 Date 10/14/2009 Company Name Integrated Diagnostics Mailing Address 1441 N. 34th Street Seattle, WA 98103 Company Description The mission of Integrated Diagnostics is to leverage powerful emerging technologies in the development of diagnostic products that enable physicians and patients to manage complex and important diseases such as cancer, diabetes and Alzheimer’s … Continue reading “Integrated Diagnostics Receives $30,000,000 Series A Funding”
Semtek Innovative Solutions Lands $6,700,000 Series B Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3ecf4fcc-bbfc-40cf-b806-b1ca2cf155f8&Preview=1 Date 10/14/2009 Company Name Semtek Innovative Solutions Mailing Address 12777 High Bluff Drive San Diego, CA 92130 Company Description Semtek Innovative Technologies Corporation has been a leader in card data capture and magnetics technology since 1999, serving public and private sector customers who require highly secure OEM components for their fixed-base … Continue reading “Semtek Innovative Solutions Lands $6,700,000 Series B Financing”
Technorati Garners $2,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c311fd42-8944-4039-a3b8-2da601f39b69&Preview=1 Date 10/14/2009 Company Name Technorati Mailing Address 665 3rd Street San Francisco, CA 94107 Company Description Technorati is the recognized authority on what’s going on in the world of weblogs. We help people search for, surface, and organize bloggers and their daily posts. Website http://www.technorati.com Transaction Type Venture Equity Transaction Amount … Continue reading “Technorati Garners $2,000,000 New Funding Round”
Illumina licenses Orchid Cellmark DNA technology
San Diego’s Illumina (NASDAQ: [[ticker: ILMN]]) has licensed worldwide rights to commercially develop Orchid Cellmark’s proprietary single base nucleotide extension technology for forensics and diagnostics. Princeton, N.J.-based Orchid (NASDAQ: [[ticker:ORCH]]) is one of the largest providers of forensic DNA testing services used by the criminal justice system. Orchid says Illumina agreed to pay $850,000 upfront … Continue reading “Illumina licenses Orchid Cellmark DNA technology”
Gist and Glympse Release iPhone Apps, Look to Capture More of the Mobile Market
Call it the iPhone “2G.” Two Seattle-area startups that start with the letter “G” are rolling out new iPhone apps today. OK, this would not normally make significant news for us, because new apps appear on a daily basis, but each of these cases provides an interesting update to the company’s mobile strategy, so here … Continue reading “Gist and Glympse Release iPhone Apps, Look to Capture More of the Mobile Market”
Decho Teams Up with Vodafone
Seattle-based Decho announced today it has formed a strategic partnership with Vodafone, a British mobile network operator, to develop cloud-based data backup services for personal computers. Financial terms of the deal were not released. The new products for European markets will be built using Mozy, the online backup service operated by Decho, which is a … Continue reading “Decho Teams Up with Vodafone”
Q3 Venture Deals Regain Some Lost Altitude, With $6B Invested Nationwide
The storm may not have entirely passed, but the venture capital industry unbattened the hatches during the three months that ended in September. At least that’s the sense I get from a 69-page report on U.S. venture investing, which we get from New York-based ChubbyBrain, an information services firm developing tools for investors, startups, and … Continue reading “Q3 Venture Deals Regain Some Lost Altitude, With $6B Invested Nationwide”
Cheezburger Still Tops Startup Index
Cheezburger Network (formerly Pet Holdings) retained its No. 1 position in Seattle 2.0’s monthly rankings of local startups’ Web traffic. The rest of the top five were Zillow, Picnik, BuddyTV, and Wetpaint. Survey Analytics made a strong jump to No. 6. Other strong gains were made by Smith & Tinker, Gist, GlobalScholar, and Seattle 2.0 … Continue reading “Cheezburger Still Tops Startup Index”
Alkermes’ Anti-Addiction Drug, Key to Company Pipeline, Passes Early Test
Alkermes, the Cambridge, MA based biotech company, said today that a strategically important drug it is developing to help people beat addictions was found in a pair of early-stage clinical trials to be safe and practical as a once-daily pill. The Alkermes drug, called ALKS 33, was found to be well-tolerated, absorbed into the bloodstream … Continue reading “Alkermes’ Anti-Addiction Drug, Key to Company Pipeline, Passes Early Test”
$92M for Rocket Software
Newton, MA-based enterprise software firm Rocket Software has raised $91.9 million in equity financing, according to an SEC filing. PeHUB reports that that the filing comes on the heels of private equity firm Court Square Capital Partners’ investment in Rocket, but that neither firm would talk about the financing. The SEC filing does not indicate … Continue reading “$92M for Rocket Software”
MIT Venture Capital Conference
The MIT Venture Capital & Private Equity Club presents the 12th annual MIT Venture Capital Conference. From the conference website: “Against the background of a quickly changing economic environment, the 2009 conference will illuminate the critical trends and opportunities available in this ‘Brave New World.’ How have dramatic shifts in the political and financial worlds … Continue reading “MIT Venture Capital Conference”
Innovation Day at the Massachusetts State House
The Joint Committee on Economic Development & Emerging Technology of the Massachusetts state legislature, together with the Massachusetts Legislative Biotechnology Caucus, the New England Venture Capital Association, MassBio, MassMEDIC, Massachusetts Technology Leadership Council, MITX and the New England Clean Energy Council, is organizing a morning of presentations by innovative technology companies in the state. The … Continue reading “Innovation Day at the Massachusetts State House”